1. Signaling Pathways
  2. Stem Cell/Wnt
    TGF-beta/Smad
  3. PKA
  4. PKAR Isoform

PKAR

PKAR1A encodes the type Iα regulatory subunit of cyclic AMP-dependent protein kinase A (PKA), a central mediator of cAMP signaling that controls phosphorylation-dependent cellular responses.[1][2] In the inactive PKA holoenzyme, two regulatory subunits associate with two catalytic subunits, and cAMP binding to the regulatory subunits releases the catalytic components to initiate downstream signaling.[1][3] Mechanistically, PKAR1A functions as a key regulator of PKA activity and thereby influences transcriptional regulation, cellular growth, differentiation, and signal transduction processes governed by the cAMP/PKA pathway.[1][2] In disease contexts, genetic alterations in PRKAR1A are linked to endocrine and developmental disorders, and the gene has also been described as a tumor-suppressor component in thyroid-related tumor biology.[2][4] Compared with related PKA regulatory isoforms, PKAR1A belongs to the type I regulatory class, whereas type II PKA complexes contain alternative regulatory subunits such as PRKAR2A or PRKAR2B that contribute to distinct intracellular localization and signaling properties.[5] This isoform-specific organization provides an important framework for dissecting compartmentalized cAMP signaling in experimental systems.[5] For research applications, pharmacological modulation is typically achieved through manipulation of cAMP-dependent PKA activation rather than direct PKAR1A-selective ligands, making PKAR1A a valuable molecular component for studying PKA-dependent signaling networks and disease-associated pathway dysregulation.[1][3]

PKAR Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-111759
    Jaspamycin
    Activator 98.94%
    Jaspamycin (7-CN-7-C-Ino) is a potent activator of PKA, binding to the R site (PKAR), with an EC50 of 6.5 nM and Kd of 8 nM in Trypanosoma brucei. Jaspamycin (7-CN-7-C-Ino) does not bind with purified human PKARIα. Anti-parasite activity.